Advertisement
Singapore markets closed

  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     

  • Nikkei

    39,583.08
    +241.54 (+0.61%)
     

  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     

  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     

  • Bitcoin USD

    60,786.27
    -750.97 (-1.22%)
     

  • CMC Crypto 200

    1,268.93
    -14.90 (-1.16%)
     

  • S&P 500

    5,490.87
    +8.00 (+0.15%)
     

  • Dow

    39,199.62
    +35.56 (+0.09%)
     

  • Nasdaq

    17,870.44
    +11.76 (+0.07%)
     

  • Gold

    2,341.90
    +5.30 (+0.23%)
     

  • Crude Oil

    81.76
    +0.02 (+0.02%)
     

  • 10-Yr Bond

    4.3390
    +0.0510 (+1.19%)
     

  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     

  • Jakarta Composite Index

    7,063.58
    +95.63 (+1.37%)
     

  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

Pacific Biosciences: Q1 Earnings Snapshot

Associated Press Finance
·1-min read

MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $78.2 million in its first quarter.

On a per-share basis, the Menlo Park, California-based company said it had a loss of 29 cents. Losses, adjusted for one-time gains and costs, were 26 cents per share.

The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 26 cents per share.

The maker of genetic analysis technology posted revenue of $38.8 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PACB at https://www.zacks.com/ap/PACB